| human | Q5 |
| P496 | ORCID iD | 0000-0002-8813-3419 |
| P69 | educated at | University of Washington | Q219563 |
| P108 | employer | University of Washington | Q219563 |
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q39708631 | "I never thought that it would happen … " Experiences of HIV seroconverters among HIV-discordant partnerships in a prospective HIV prevention study in Kenya |
| Q33693690 | 'If I am given antiretrovirals I will think I am nearing the grave': Kenyan HIV serodiscordant couples' attitudes regarding early initiation of antiretroviral therapy |
| Q35751859 | 'If you are circumcised, you are the best': understandings and perceptions of voluntary medical male circumcision among men from KwaZulu-Natal, South Africa |
| Q55057171 | 1224Defining herpes simplex virus type 2 sequence heterogeneity using next generation sequencing. |
| Q35882621 | A Scoring Tool to Identify East African HIV-1 Serodiscordant Partnerships with a High Likelihood of Pregnancy |
| Q64262634 | A clinic-based tablet application to support safer conception among HIV serodiscordant couples in Kenya: feasibility and acceptability study |
| Q33812743 | A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation |
| Q38850686 | A cross-sectional analysis of Trichomonas vaginalis infection among heterosexual HIV-1 serodiscordant African couples |
| Q34792200 | A post-trial assessment of factors influencing study drug adherence in a randomized biomedical HIV-1 prevention trial |
| Q44014076 | A prospective study of contraceptive use among African women in HIV-1 serodiscordant partnerships |
| Q37032078 | A prospective study of frequency and correlates of intimate partner violence among African heterosexual HIV serodiscordant couples |
| Q37503505 | A prospective study of the effect of pregnancy on CD4 counts and plasma HIV-1 RNA concentrations of antiretroviral-naive HIV-1-infected women |
| Q37598617 | A qualitative study of barriers to consistent condom use among HIV-1 serodiscordant couples in Kenya |
| Q40482057 | ART coverage in Rwanda: successes and remaining challenges. |
| Q73179863 | Acceptability of a bioadhesive nonoxynol-9 gel delivered by an applicator as a rectal microbicide |
| Q36487827 | Acyclovir Prophylaxis Reduces the Incidence of Herpes Zoster Among HIV-Infected Individuals: Results of a Randomized Clinical Trial |
| Q35941348 | Acyclovir achieves a lower concentration in African HIV-seronegative, herpes simplex virus 2-seropositive women than in non-African populations |
| Q33727305 | Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. |
| Q36525470 | Adenovirus types 2, 8, and 37 associated with genital infections in patients attending a sexually transmitted disease clinic |
| Q28533158 | Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa |
| Q101049580 | Adherence to recommendations for ART and targeted PrEP use among HIV serodiscordant couples in East Africa: the "PrEP as a bridge to ART" strategy |
| Q102975513 | Adolescent healthcare: I'm Lovin' it |
| Q100393377 | Alignment of PrEP use and effective contraceptive use among East African women in HIV serodiscordant partnerships |
| Q38849535 | Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence |
| Q36750843 | An empiric risk scoring tool for identifying high-risk heterosexual HIV-1-serodiscordant couples for targeted HIV-1 prevention |
| Q96692156 | An implementation study of oral and blood-based HIV self-testing and linkage to care among men in rural and peri-urban KwaZulu-Natal, South Africa |
| Q52104906 | An individually tailored intervention for HIV prevention: baseline data from the EXPLORE Study. |
| Q34314648 | An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in Uganda |
| Q80472000 | Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1 |
| Q36812840 | Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons |
| Q38852013 | Antiretroviral Therapy Initiation Is Not Associated With Risky Sexual Behavior Among Heterosexual Human Immunodeficiency Virus-Infected Persons in Serodiscordant Partnerships |
| Q43430492 | Antiretroviral preexposure prophylaxis for HIV prevention |
| Q28270788 | Antiretroviral prophylaxis for HIV prevention in heterosexual men and women |
| Q81389036 | Antiretroviral therapy for HIV-1 vaccine efficacy trial participants who seroconvert |
| Q36493442 | Antiretroviral-based HIV-1 prevention: antiretroviral treatment and pre-exposure prophylaxis |
| Q30233615 | Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. |
| Q34738291 | Association between male circumcision and incidence of syphilis in men and women: a prospective study in HIV-1 serodiscordant heterosexual African couples |
| Q45410894 | Association of herpes simplex virus type 2 infection and syphilis with human immunodeficiency virus infection among men who have sex with men in Peru |
| Q96680172 | Associations between schistosomiasis and HIV-1 acquisition risk in four prospective cohorts: a nested case-control analysis |
| Q99719056 | Bacterial vaginosis and risk of HIV infection in the context of CD101 gene variation |
| Q21144606 | Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples |
| Q42205362 | Bending the curve: maximising impact with focused HIV prevention |
| Q61446465 | Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couples |
| Q35817533 | Biomedical HIV Prevention Including Pre-exposure Prophylaxis and Opiate Agonist Therapy for Women Who Inject Drugs: State of Research and Future Directions |
| Q80419720 | Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160 |
| Q46479831 | Brief Report: Context Matters: PrEP Adherence is Associated With Sexual Behavior Among HIV Serodiscordant Couples in East Africa |
| Q47580343 | Brief Report: Frequency of Monitoring Kidney Function in HIV-Uninfected Persons Using Daily Oral Tenofovir Disoproxil Fumarate Pre-exposure Prophylaxis |
| Q38850925 | Brief Report: Medication Sharing Is Rare Among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention |
| Q88919197 | C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa |
| Q35163040 | Changes in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trial |
| Q33436735 | Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study |
| Q28744206 | Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention |
| Q28390463 | Circumcision of male children for reduction of future risk for HIV: acceptability among HIV serodiscordant couples in Kampala, Uganda |
| Q36729580 | Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infection |
| Q33797142 | Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial |
| Q35630400 | Clinical and virologic response to episodic acyclovir for genital ulcers among HIV-1 seronegative, herpes simplex virus type 2 seropositive African women: a randomized, placebo-controlled trial |
| Q45735843 | Clinical challenges and diagnostic approaches to recognizing acute human immunodeficiency virus infection |
| Q46866048 | Closing the gaps in the HIV care continuum |
| Q22252603 | Combination HIV prevention: significance, challenges, and opportunities |
| Q99708030 | Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trial |
| Q33554294 | Community-based strategies to strengthen men's engagement in the HIV care cascade in sub-Saharan Africa |
| Q37881636 | Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay |
| Q38856099 | Comparison of subjective and objective adherence measures for preexposure prophylaxis against HIV infection among serodiscordant couples in East Africa |
| Q93162011 | Comparisons of Human Immunodeficiency Virus Type 1 Envelope Variants in Blood and Genital Fluids near the Time of Male-to-Female Transmission |
| Q48142377 | Completion of the tuberculosis care cascade in a community-based HIV linkage-to-care study in South Africa and Uganda |
| Q38823078 | Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial |
| Q37598620 | Contraceptive method and pregnancy incidence among women in HIV-1-serodiscordant partnerships |
| Q57096719 | Control of sexually transmitted infections for HIV prevention |
| Q45905749 | Correction: Genomewide Association Study for Determinants of HIV-1 Acquisition and Viral Set Point in HIV-1 Serodiscordant Couples with Quantified Virus Exposure. |
| Q64235555 | Correction: Whole genome sequencing of extreme phenotypes identifies variants in CD101 and UBE2V1 associated with increased risk of sexually acquired HIV-1 |
| Q101226089 | Correlates of HIV status non-disclosure by pregnant women living with HIV to their male partners in Uganda: a cross-sectional study |
| Q30233723 | Correlates of condom failure in a sexually active cohort of men who have sex with men. |
| Q34120978 | Correlates of prevalent and incident Kaposi's sarcoma-associated herpesvirus infection in men who have sex with men. |
| Q37042078 | Correlation between pill counts and biologic effects in an HIV-1 prevention clinical trial: implications for measuring adherence |
| Q88715157 | Cost of Integrating Noncommunicable Disease Screening Into Home-Based HIV Testing and Counseling in South Africa |
| Q35262551 | Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis |
| Q104515433 | Cost-effectiveness of point-of-care testing with task-shifting for HIV care in South Africa: a modelling study |
| Q35875751 | Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda |
| Q33552342 | Could misreporting of condom use explain the observed association between injectable hormonal contraceptives and HIV acquisition risk? |
| Q37488475 | Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention |
| Q100486037 | Covid-19, Ebola, and HIV - Leveraging Lessons to Maximize Impact |
| Q30431147 | Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection |
| Q92777549 | Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100-200 cells/mm3 |
| Q33881449 | Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial |
| Q37212998 | Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial |
| Q38861991 | Daily oral tenofovir and emtricitabine-tenofovir preexposure prophylaxis reduces herpes simplex virus type 2 acquisition among heterosexual HIV-1-uninfected men and women: a subgroup analysis of a randomized trial |
| Q37266072 | Daily short message service surveys to measure sexual behavior and pre-exposure prophylaxis use among Kenyan men and women |
| Q98231948 | Defining gaps in pre-exposure prophylaxis delivery for pregnant and post-partum women in high-burden settings using an implementation science framework |
| Q33831463 | Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnerships |
| Q39452876 | Delayed presentation to clinics for sexually transmitted diseases by symptomatic patients. A potential contributor to continuing STD morbidity |
| Q40265835 | Delivering safer conception services to HIV serodiscordant couples in Kenya: perspectives from healthcare providers and HIV serodiscordant couples |
| Q39565812 | Demographic rather than behavioral risk factors predict herpes simplex virus type 2 infection in sexually active adolescents |
| Q38849906 | Depression and ART Initiation Among HIV Serodiscordant Couples in Kenya and Uganda |
| Q52585991 | Depression and anxiety as risk factors for delayed care-seeking behavior in HIV positive individuals in South Africa. |
| Q34030252 | Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples |
| Q40751062 | Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations |
| Q35043592 | Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial |
| Q43061433 | Don't ask, don't tell: patterns of HIV disclosure among HIV positive men who have sex with men with recent STI practising high risk behaviour in Los Angeles and Seattle |
| Q90026395 | Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections |
| Q47184537 | Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: A nested cross-sectional viral genotyping study. |
| Q30233637 | Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load |
| Q36497840 | Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant Couples |
| Q59810828 | Effect of Depression on Adherence to Oral PrEP Among Men and Women in East Africa |
| Q37488423 | Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women |
| Q37114698 | Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial |
| Q34244796 | Effect of acyclovir on HIV-1 set point among herpes simplex virus type 2-seropositive persons during early HIV-1 infection |
| Q36566659 | Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy |
| Q96128897 | Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a ran |
| Q38667599 | Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study |
| Q37441854 | Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial |
| Q92489546 | Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading? |
| Q36132607 | Empowering patients to link to care and treatment: qualitative findings about the role of a home-based HIV counselling, testing and linkage intervention in South Africa |
| Q28547154 | Estimating PMTCT's Impact on Heterosexual HIV Transmission: A Mathematical Modeling Analysis |
| Q36251754 | Estimating efficacy in a randomized trial with product nonadherence: application of multiple methods to a trial of preexposure prophylaxis for HIV prevention |
| Q35007321 | Estimating the cost-effectiveness of pre-exposure prophylaxis to reduce HIV-1 and HSV-2 incidence in HIV-serodiscordant couples in South Africa |
| Q33697958 | Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk |
| Q36897844 | Estimating the impact of universal antiretroviral therapy for HIV serodiscordant couples through home HIV testing: insights from mathematical models |
| Q92915247 | Ethical considerations for new HIV prevention trials |
| Q94928489 | Evaluation of a behavior-centered design strategy for creating demand for oral PrEP among young women in Cape Town, South Africa |
| Q50066790 | Evaluation of the association between the concentrations of key vaginal bacteria and the increased risk of HIV acquisition in African women from five cohorts: a nested case-control study. |
| Q45414710 | Excellent safety and tolerability of the human immunodeficiency virus type 1 pGA2/JS2 plasmid DNA priming vector vaccine in HIV type 1 uninfected adults |
| Q45722840 | Factors associated with oropharyngeal human immunodeficiency virus shedding |
| Q33787661 | Feasibility and acceptability of HIV self-testing among pre-exposure prophylaxis users in Kenya |
| Q36006803 | Fertility Decision-Making Among Kenyan HIV-Serodiscordant Couples Who Recently Conceived: Implications for Safer Conception Planning |
| Q40046119 | Fertility Intentions, Pregnancy, and Use of PrEP and ART for Safer Conception Among East African HIV Serodiscordant Couples |
| Q36760734 | Fertility intentions and interest in early antiretroviral therapy among East African HIV-1-infected individuals in serodiscordant partnerships |
| Q35464075 | Frequency of false positive rapid HIV serologic tests in African men and women receiving PrEP for HIV prevention: implications for programmatic roll-out of biomedical interventions |
| Q28751027 | Frequent detection of human adenovirus from the lower gastrointestinal tract in men who have sex with men |
| Q33697680 | Gender-Specific Combination HIV Prevention for Youth in High-Burden Settings: The MP3 Youth Observational Pilot Study Protocol. |
| Q34920252 | Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission |
| Q35882385 | Genital herpes and human immunodeficiency virus: double trouble |
| Q33336603 | Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa |
| Q38872373 | Genital ulcer disease treatment policies and access to acyclovir in eight sub-Saharan African countries |
| Q29417004 | Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure |
| Q33715126 | Global risk of sexually transmitted diseases. |
| Q37409772 | HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy |
| Q37546766 | HIV diversity as a biomarker for HIV incidence estimation: including a high-resolution melting diversity assay in a multiassay algorithm |
| Q36495553 | HIV incidence determination in the United States: a multiassay approach |
| Q34662270 | HIV infection: epidemiology, pathogenesis, treatment, and prevention |
| Q92063126 | HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery |
| Q28258739 | HIV preexposure prophylaxis: new data and potential use |
| Q33763000 | HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention |
| Q31042536 | HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE Study |
| Q48490664 | HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial |
| Q45105746 | HIV, syphilis and heterosexual bridging among Peruvian men who have sex with men. |
| Q56591988 | HIV-1 Infection in Individuals With the CCR5-Δ32/Δ32 Genotype: Acquisition of Syncytium-Inducing Virus at Seroconversion |
| Q30233544 | HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion |
| Q26996011 | HIV-1 prevention for HIV-1 serodiscordant couples |
| Q42919016 | HIV-1 prevention with ART and PrEP: mathematical modeling insights into resistance, effectiveness, and public health impact |
| Q33874874 | HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couples |
| Q40576587 | HIV-1 vaccination administered intramuscularly can induce both systemic and mucosal T cell immunity in HIV-1-uninfected individuals |
| Q51071775 | HIV-1, sexually transmitted infections, and sexual behavior trends among men who have sex with men in Lima, Peru. |
| Q90412714 | HIV-Uninfected Kenyan Adolescent and Young Women Share Perspectives on Using Preexposure Prophylaxis During Pregnancy |
| Q37255124 | HSV suppression reduces seminal HIV-1 levels in HIV-1/HSV-2 co-infected men who have sex with men. |
| Q39198905 | Herpes Simplex Virus Suppressive Therapy in Herpes Simplex Virus-2/Human Immunodeficiency Virus-1 Coinfected Women Is Associated With Reduced Systemic CXCL10 But Not Genital Cytokines |
| Q40223007 | Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study |
| Q45399240 | Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial |
| Q37149672 | Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial |
| Q45752986 | Herpes simplex virus shedding among human immunodeficiency virus-negative men who have sex with men: site and frequency of shedding |
| Q39534257 | Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. |
| Q45729656 | Herpes simplex virus type 2 infection as a risk factor for human immunodeficiency virus acquisition in men who have sex with men. |
| Q44032584 | Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors |
| Q34508433 | Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons |
| Q104283852 | Heterogeneity in individual preferences for HIV testing: A systematic literature review of discrete choice experiments |
| Q34067511 | Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis |
| Q37097828 | High HIV testing uptake and linkage to care in a novel program of home-based HIV counseling and testing with facilitated referral in KwaZulu-Natal, South Africa |
| Q40045231 | High levels of viral suppression among East African HIV-infected women and men in serodiscordant partnerships initiating antiretroviral therapy with high CD4 counts and during pregnancy |
| Q34110847 | High medication adherence during periconception periods among HIV-1-uninfected women participating in a clinical trial of antiretroviral pre-exposure prophylaxis |
| Q46494765 | High prevalence of HIV and non-communicable disease (NCD) risk factors in rural KwaZulu-Natal, South Africa |
| Q45413573 | High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study |
| Q35639207 | High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a randomized, crossover trial |
| Q56897894 | High-risk behaviors among men who have sex with men in 6 US cities: baseline data from the EXPLORE Study |
| Q44806143 | Higher concentration of HIV RNA in rectal mucosa secretions than in blood and seminal plasma, among men who have sex with men, independent of antiretroviral therapy |
| Q40121437 | Highly conserved intragenic HSV-2 sequences: Results from next-generation sequencing of HSV-2 UL and US regions from genital swabs collected from 3 continents |
| Q37052795 | Home testing and counselling to reduce HIV incidence in a generalised epidemic setting: a mathematical modelling analysis |
| Q30233590 | Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection. |
| Q37088950 | Hormonal contraceptive use and risk of HIV-1 disease progression |
| Q34525382 | Household-based HIV counseling and testing as a platform for referral to HIV care and medical male circumcision in Uganda: a pilot evaluation |
| Q57319648 | How Many Interviews Are Enough? |
| Q37054402 | How home HIV testing and counselling with follow-up support achieves high testing coverage and linkage to treatment and prevention: a qualitative analysis from Uganda |
| Q34439417 | Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypes |
| Q104105001 | Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial |
| Q36580115 | I Knew I Would Be Safer. Experiences of Kenyan HIV Serodiscordant Couples Soon After Pre-Exposure Prophylaxis (PrEP) Initiation |
| Q52681670 | Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection. |
| Q36509801 | Immune response to hepatitis B virus vaccination among HIV-1 infected and uninfected adults in Kenya |
| Q95729764 | Impact of Tenofovir-Based Pre-exposure Prophylaxis on Biomarkers of Bone Formation, Bone Resorption, and Bone Mineral Metabolism in HIV-Negative Adults |
| Q64069102 | Implementation of a comprehensive safer conception intervention for HIV-serodiscordant couples in Kenya: uptake, use and effectiveness |
| Q103031935 | Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial |
| Q37879815 | Incidence of HIV and sexually transmitted diseases (STD) in a cohort of HIV-negative men who have sex with men (MSM). |
| Q46234179 | Incidence of salmonellosis in patients with AIDS. |
| Q54260529 | Increased Risk of Female HIV-1 Acquisition Throughout Pregnancy and Postpartum: A Prospective Per-coital Act Analysis Among Women with HIV-1 Infected Partners. |
| Q35214337 | Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples |
| Q67594910 | Indeterminate HIV-1 western blots: implications and considerations for widespread HIV testing |
| Q22242897 | Indeterminate Human Immunodeficiency Virus Type 1 Western Blots: Seroconversion Risk, Specificity of Supplemental Tests, and an Algorithm for Evaluation |
| Q35101431 | Induction of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses in HIV vaccine trial participants who subsequently acquire HIV-1 infection |
| Q26823594 | Infectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventions |
| Q34938105 | Initiation of antiretroviral therapy and viral suppression after home HIV testing and counselling in KwaZulu-Natal, South Africa, and Mbarara district, Uganda: a prospective, observational intervention study |
| Q36110276 | Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda |
| Q54961974 | Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1 serodiscordant couples in East Africa: a qualitative evaluation study in Uganda. |
| Q37003069 | Integrated strategies for combination HIV prevention: principles and examples for men who have sex with men in the Americas and heterosexual African populations |
| Q64234540 | Integrating hypertension screening at the time of voluntary HIV testing among adults in South Africa |
| Q103738605 | Interventions to improve daily medication use among adolescents and young adults: what can we learn for youth PrEP services? |
| Q37341579 | Intimate Partner Violence and Adherence to HIV Pre-exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships: A Prospective Cohort Study |
| Q46936264 | Intimate partner violence and self-reported pre-exposure prophylaxis (PrEP) interruptions among HIV-negative partners in HIV serodiscordant couples in Kenya and Uganda |
| Q28388043 | Knowledge and attitudes about male circumcision for HIV-1 prevention among heterosexual HIV-1 serodiscordant partnerships in Kampala, Uganda |
| Q101044834 | Knowledge and barriers of PrEP delivery among diverse groups of potential PrEP users in Central Uganda |
| Q35558214 | Lay Social Resources for Support of Adherence to Antiretroviral Prophylaxis for HIV Prevention Among Serodiscordant Couples in sub-Saharan Africa: A Qualitative Study |
| Q89840863 | Lessons on PrEP from the SEARCH study in east Africa |
| Q57207390 | Linking HIV and Antiretroviral Drug Resistance Surveillance in Peru |
| Q96692168 | Lottery incentives have short-term impact on ART initiation among men: results from a randomized pilot study |
| Q38855217 | Low Risk of Proximal Tubular Dysfunction Associated With Emtricitabine-Tenofovir Disoproxil Fumarate Preexposure Prophylaxis in Men and Women |
| Q38874137 | Male circumcision and HIV risks and benefits for women |
| Q35059756 | Male circumcision and risk of HIV acquisition among MSM |
| Q34058693 | Male circumcision and risk of male-to-female HIV-1 transmission: a multinational prospective study in African HIV-1-serodiscordant couples |
| Q45415130 | Management of herpes simplex virus type 2 infection in HIV type 1-infected persons |
| Q39127005 | Markov Mixed Effects Modeling Using Electronic Adherence Monitoring Records Identifies Influential Covariates to HIV Preexposure Prophylaxis |
| Q46005603 | Maternal tenofovir disoproxil fumarate use during pregnancy is not associated with adverse perinatal outcomes among HIV-infected East African women: a prospective study. |
| Q55001575 | Messaging Circumstances and Economic Pressures as Influences on Linkage to Medical Male Circumcision following Community-Based HIV Testing for Men in Rural Southwest Uganda: A Qualitative Study. |
| Q98722443 | Model-based predictions of HIV incidence among African women using HIV risk behaviors and community-level data on male HIV prevalence and viral suppression |
| Q46091440 | Modeling HIV disease progression and transmission at population-level: The potential impact of modifying disease progression in HIV treatment programs |
| Q34468239 | Mortality in members of HIV-1 serodiscordant couples in Africa and implications for antiretroviral therapy initiation: results of analyses from a multicenter randomized trial |
| Q50194198 | Motivated Reasoning and HIV Risk? Views on Relationships, Trust, and Risk from Young Women in Cape Town, South Africa, and Implications for Oral PrEP. |
| Q48483630 | Motivations for participating in an HIV vaccine efficacy trial |
| Q33924644 | Mucosal shedding of human herpesvirus 8 in men. |
| Q33864578 | My intention was a child but I was very afraid: fertility intentions and HIV risk perceptions among HIV-serodiscordant couples experiencing pregnancy in Kenya |
| Q104571247 | Narrative sexual histories and perceptions of HIV risk among young women taking PrEP in southern Africa: Findings from a novel participatory method |
| Q104141915 | Neutralizing Activity of Broadly Neutralizing anti-HIV-1 Antibodies against Primary African Isolates |
| Q46110756 | New insights on interactions between HIV-1 and HSV-2. |
| Q91158036 | No Evidence of Sexual Risk Compensation Following PrEP Initiation Among Heterosexual HIV Serodiscordant Couples in Kenya and Uganda |
| Q46389674 | OA01-06 LB. HIV-1 plasma RNA and risk of HIV-1 transmission |
| Q40517790 | Objective Measurement of Inaccurate Condom Use Reporting Among Women Using Depot Medroxyprogesterone Acetate for Contraception |
| Q34081339 | Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study |
| Q36409225 | Oral antiretroviral chemoprophylaxis: current status |
| Q34548181 | Oral herpes simplex virus type 2 reactivation in HIV-positive and -negative men. |
| Q35613315 | Outside sexual partnerships and risk of HIV acquisition for HIV uninfected partners in African HIV serodiscordant partnerships |
| Q73101510 | Overcoming barriers to HIV testing: preferences for new strategies among clients of a needle exchange, a sexually transmitted disease clinic, and sex venues for men who have sex with men |
| Q55717188 | P11-17. Intermittent rectal shedding of multiple human adenovirus serotypes among HIV-positive MSM. |
| Q70219167 | Palpable purpura associated with Corynebacterium jeikeium endocarditis |
| Q36509600 | Partner characteristics predicting HIV-1 set point in sexually acquired HIV-1 among African seroconverters |
| Q80210018 | Partner-specific sexual behavioral differences between phase 3 HIV vaccine efficacy trial participants and controls: Project VISION |
| Q38554928 | Patients attending STD clinics in an evolving health care environment. Demographics, insurance coverage, preferences for STD services, and STD morbidity |
| Q34312280 | Patterns of Medicaid eligibility: a sample of 408 Medi-Cal eligibles in San Francisco, California |
| Q56911319 | Patterns of Oral PrEP Adherence and HIV Risk Among Eastern African Women in HIV Serodiscordant Partnerships |
| Q36565716 | Patterns of human herpesvirus-8 oral shedding among diverse cohorts of human herpesvirus-8 seropositive persons |
| Q38853819 | Perceived Risk Among Human Immunodeficiency Virus Serodiscordant Couples in East Africa Taking Oral Pre-Exposure Prophylaxis |
| Q64941484 | Perceptions of pregnancy occurring among HIV-serodiscordant couples in Kenya. |
| Q37883309 | Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy |
| Q35080053 | Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States |
| Q34734012 | Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countries |
| Q37172505 | Periconception pre-exposure prophylaxis to prevent HIV transmission: benefits, risks, and challenges to implementation |
| Q37869495 | Pilot study of COBAS PCR and ligase chain reaction for detection of rectal infections due to Chlamydia trachomatis |
| Q35661895 | Plasma cytokine levels and risk of HIV type 1 (HIV-1) transmission and acquisition: a nested case-control study among HIV-1-serodiscordant couples |
| Q36641658 | Plasma viral loads during early HIV-1 infection are similar in subtype C- and non-subtype C-infected African seroconverters |
| Q89916776 | Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial |
| Q97078290 | Point-of-care and Near Real-time Testing for Antiretroviral Adherence Monitoring to HIV Treatment and Prevention |
| Q37203867 | Population Pharmacokinetics of Tenofovir in HIV-1-Uninfected Members of Serodiscordant Couples and Effect of Dose Reporting Methods |
| Q43890422 | Possible potentiation of warfarin by fluconazole |
| Q35997337 | Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection |
| Q90693843 | PrEP Discontinuation and Prevention-Effective Adherence: Experiences of PrEP Users in Ugandan HIV Serodiscordant Couples |
| Q42696079 | PrEP Use During Periods of HIV Risk Among East African Women in Serodiscordant Relationships |
| Q91766283 | PrEP for HIV Prevention: Evidence, Global Scale-up, and Emerging Options |
| Q28554369 | Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption |
| Q92121091 | Pre-exposure prophylaxis differentially alters circulating and mucosal immune cell activation in herpes simplex virus type 2 seropositive women |
| Q34436959 | Pre-exposure prophylaxis does not affect the fertility of HIV-1-uninfected men |
| Q34060282 | Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception |
| Q55950193 | Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa |
| Q56913069 | Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa |
| Q37366545 | Prediction of HIV acquisition among men who have sex with men. |
| Q34700364 | Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception |
| Q36438778 | Preexposure prophylaxis-selected drug resistance decays rapidly after drug cessation |
| Q34021932 | Preferences for daily or intermittent pre-exposure prophylaxis regimens and ability to anticipate sex among HIV uninfected members of Kenyan HIV serodiscordant couples |
| Q35184560 | Pregnancy incidence and outcomes among women receiving preexposure prophylaxis for HIV prevention: a randomized clinical trial |
| Q56911496 | Pregnancy outcomes and infant growth among babies with in-utero exposure to tenofovir-based preexposure prophylaxis for HIV prevention |
| Q33753930 | Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women |
| Q123223431 | Pregnant women and male partner perspectives of secondary distribution of HIV self-testing kits in Uganda: A qualitative study |
| Q35110728 | Prevalence and correlates of human herpesvirus 8 infection among Peruvian men who have sex with men. |
| Q37352564 | Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa |
| Q41927589 | Protocol for a randomised controlled implementation trial of point-of-care viral load testing and task shifting: the Simplifying HIV TREAtment and Monitoring (STREAM) study |
| Q57297788 | Quadrivalent HPV vaccine in HIV-1-infected early adolescent girls and boys in Kenya: Month 7 and 12 post vaccine immunogenicity and correlation with immune status |
| Q36253005 | Quantifying ongoing HIV-1 exposure in HIV-1-serodiscordant couples to identify individuals with potential host resistance to HIV-1 |
| Q35808857 | Rapid Antiretroviral Therapy Initiation for Women in an HIV-1 Prevention Clinical Trial Experiencing Primary HIV-1 Infection during Pregnancy or Breastfeeding |
| Q90744549 | Reaching the 90-90-90 target: lessons from HIV self-testing |
| Q30233765 | Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States |
| Q30233761 | Rectal microbicides for U.S. gay men. Are clinical trials needed? Are they feasible? HIVNET Vaccine Preparedness Study Protocol Team |
| Q33313869 | Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial |
| Q36900870 | Regulatory T-Cell Activity But Not Conventional HIV-Specific T-Cell Responses Are Associated With Protection From HIV-1 Infection |
| Q43495846 | Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibility |
| Q42602285 | Response to "Oral PrEP for young African women and men". |
| Q35875710 | Rethinking HIV prevention to prepare for oral PrEP implementation for young African women |
| Q36629910 | Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis |
| Q33846603 | Risk Factors for HSV-2 Infection among Sexual Partners of HSV-2/HIV-1 Co-Infected Persons |
| Q72677969 | Risk factors for repeatedly reactive HIV-1 EIA and indeterminate western blots. A population-based case-control study |
| Q35473551 | Risk of drug resistance among persons acquiring HIV within a randomized clinical trial of single- or dual-agent preexposure prophylaxis |
| Q49888789 | Safer conception among HIV-1 serodiscordant couples in East Africa: understanding knowledge, attitudes, and experiences |
| Q40599389 | Safety and acceptability of the Reality condom for anal sex among men who have sex with men. |
| Q45737847 | Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers |
| Q52536992 | Safety and toxicity of nonoxynol-9 gel as a rectal microbicide. |
| Q91356458 | Schistosomiasis was not associated with higher HIV-1 plasma or genital set point viral loads among HIV seroconverters from four cohort studies |
| Q37882522 | Selective screening for chlamydial infection in women: a comparison of three sets of criteria |
| Q37033062 | Seminal HIV-1 RNA Detection in Heterosexual African Men Initiating Antiretroviral Therapy |
| Q34670442 | Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans |
| Q45284575 | Serodiscordancy and HIV prevention in sub-Saharan Africa |
| Q34673391 | Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case-control study |
| Q92566269 | Sexual Behavior and Perceived HIV Risk Among HIV-Negative Members of Serodiscordant Couples in East Africa |
| Q97549441 | Sexual behaviors following PrEP discontinuation among HIV serodiscordant couples in Kenya and Uganda |
| Q37577222 | Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis |
| Q52036335 | Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion. |
| Q30233059 | Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States |
| Q37871144 | Sexually transmitted diseases and human immunodeficiency virus-discordant partnerships among men who have sex with men. |
| Q90301032 | Sexually transmitted infections among African women: an opportunity for combination sexually transmitted infection/HIV prevention |
| Q95784281 | Sexually transmitted infections among African women: an underrecognized epidemic and an opportunity for combination STI/HIV prevention |
| Q34151789 | Sexually transmitted infections and HIV: epidemiology and interventions |
| Q36250409 | Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries |
| Q44884906 | Substance use and sexual risk: a participant- and episode-level analysis among a cohort of men who have sex with men. |
| Q38862423 | Successful discontinuation of the placebo arm and provision of an effective HIV prevention product after a positive interim efficacy result: the partners PrEP study experience |
| Q36757634 | Successful increase in contraceptive uptake among Kenyan HIV-1-serodiscordant couples enrolled in an HIV-1 prevention trial |
| Q37265920 | Summary measures of adherence using pill counts in two HIV prevention trials: the need for standardisation in reporting |
| Q42341770 | Supporting people living with HIV in serodiscordant partnerships to attempt a desired pregnancy by integrating sexual and reproductive health and HIV interventions |
| Q60944627 | Syphilis in Women |
| Q37061624 | Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxis |
| Q35131207 | Tailored combination prevention packages and PrEP for young key populations |
| Q37153328 | Taking HIV Testing to Families: Designing a Family-Based Intervention to Facilitate HIV Testing, Disclosure, and Intergenerational Communication |
| Q56910156 | Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis |
| Q64105390 | Tenofovir-Diphosphate as a Marker of HIV Pre-exposure Prophylaxis Use Among East African Men and Women |
| Q36443803 | Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women |
| Q22242692 | Tenofovir-based pre-exposure prophylaxis for HIV prevention |
| Q92751875 | The Effect of Depression on Adherence to HIV Pre-exposure Prophylaxis Among High-Risk South African Women in HPTN 067/ADAPT |
| Q64899305 | The Incremental Cost of Delivering PrEP as a Bridge to ART for HIV Serodiscordant Couples in Public HIV Care Clinics in Kenya. |
| Q91419385 | The Political, Research, Programmatic, and Social Responses to Adolescent Sexual and Reproductive Health and Rights in the 25 Years Since the International Conference on Population and Development |
| Q37854050 | The association between lack of circumcision and HIV, HSV-2, and other sexually transmitted infections among men who have sex with men. |
| Q86340652 | The changing virulence of HIV |
| Q34142034 | The clinical manifestations and treatment of sexually transmitted diseases in human immunodeficiency virus-positive men. |
| Q38849706 | The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion |
| Q35691394 | The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics |
| Q90124011 | The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study |
| Q45645853 | The interaction between herpes simplex virus and human immunodeficiency virus |
| Q36199065 | The role of anti-HSV therapeutics in the HIV-infected host and in controlling the HIV epidemic. |
| Q37876658 | To notify or not to notify: STD patients' perspectives of partner notification in Seattle |
| Q35910947 | Toll-like receptor gene variants and bacterial vaginosis among HIV-1 infected and uninfected African women |
| Q37719760 | Toll-like receptor polymorphism associations with HIV-1 outcomes among sub-Saharan Africans |
| Q40857276 | Transient Increase in Herpes Simplex Virus Type 2 (HSV-2)-Associated Genital Ulcers Following Initiation of Antiretroviral Therapy in HIV/HSV-2-Coinfected Individuals. |
| Q37307684 | Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning? |
| Q36301349 | Treatment with valacyclovir, famciclovir, or antiretrovirals reduces human herpesvirus-8 replication in HIV-1 seropositive men. |
| Q44222679 | Trichinosis with ventilatory failure and persistent myocarditis |
| Q98943947 | Tuberculosis-related stigma among adults presenting for HIV testing in KwaZulu-Natal, South Africa |
| Q34571215 | Understanding the potential impact of a combination HIV prevention intervention in a hyper-endemic community. |
| Q37503472 | Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study |
| Q98612094 | Uptake and impact of facility-based HIV self-testing on PrEP delivery: a pilot study among young women in Kisumu, Kenya |
| Q36855625 | Uptake of antiretroviral therapy and male circumcision after community-based HIV testing and strategies for linkage to care versus standard clinic referral: a multisite, open-label, randomised controlled trial in South Africa and Uganda |
| Q37874349 | Urine-based screening for Chlamydia trachomatis in men attending sexually transmitted disease clinics |
| Q44864716 | Use of a glycoprotein G-based type-specific assay to detect antibodies to herpes simplex virus type 2 among persons attending sexually transmitted disease clinics |
| Q28743210 | Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection |
| Q36165500 | Use of a risk scoring tool to identify higher-risk HIV-1 serodiscordant couples for an antiretroviral-based HIV-1 prevention intervention |
| Q34190321 | Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials |
| Q35699938 | Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study |
| Q57118204 | Use of reality "female condoms" for anal sex by US men who have sex with men. HIVNET Vaccine Preparedness Study Protocol Team |
| Q34515366 | Using plasma viral load to guide antiretroviral therapy initiation to prevent HIV-1 transmission |
| Q64107131 | Validation of clinic-based cryptococcal antigen lateral flow assay screening in HIV-infected adults in South Africa |
| Q33630030 | Variants in host viral replication cycle genes are associated with heterosexual HIV-1 acquisition in Africans |
| Q33844706 | Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial |
| Q37304108 | What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples |
| Q45812682 | Whole genome sequencing of extreme phenotypes identifies variants in CD101 and UBE2V1 associated with increased risk of sexually acquired HIV-1. |
| Q34145112 | Will circumcision provide even more protection from HIV to women and men? New estimates of the population impact of circumcision interventions |
| Q36188123 | Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies |
| Q37695200 | Worldwide circulation of HSV-2 × HSV-1 recombinant strains |
| Q36602040 | Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships |
Search more.